ArticleProceedings of the National Academy of Sciences of the United States of America2021

Computational modeling identifies multitargeted kinase inhibitors as effective therapies for metastatic, castration-resistant prostate cancer.

Thomas Bello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.